BIOMAT Database Logo BIOMAT Database Logo

Soluble guanylyl cyclase and platelet function. 1994

W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Division of Clinical Pharmacology, Medizinische Klinik, Klinikum Innenstadt der Universität, München, Germany.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006162 Guanylate Cyclase An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2. Guanyl Cyclase,Deoxyguanylate Cyclase,Guanylyl Cyclase,Inosinate Cyclase,Cyclase, Deoxyguanylate,Cyclase, Guanyl,Cyclase, Guanylate,Cyclase, Guanylyl,Cyclase, Inosinate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions

Related Publications

W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
[Soluble guanylyl cyclase].
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
The effect of hypercholesterolemia on platelet soluble guanylyl cyclase.
October 2003, Vascular pharmacology,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Characterization of soluble platelet guanylyl cyclase with peptide antibodies.
November 1992, Naunyn-Schmiedeberg's archives of pharmacology,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
September 2011, Blood,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Structure/function of the soluble guanylyl cyclase catalytic domain.
July 2018, Nitric oxide : biology and chemistry,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Modulators of soluble guanylyl cyclase.
July 1998, Naunyn-Schmiedeberg's archives of pharmacology,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase.
November 2011, AIDS (London, England),
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Soluble guanylyl cyclase: structure and regulation.
January 1999, Reviews of physiology, biochemistry and pharmacology,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.
December 2014, American journal of physiology. Heart and circulatory physiology,
W A Buechler, and K Ivanova, and G Wolfram, and C Drummer, and J M Heim, and R Gerzer
Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries.
October 2021, International journal of molecular sciences,
Copied contents to your clipboard!